QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Quantify Research launches Evidence Review and Synthesis business unit together with its expansion to the Asia-Pacific market
STOCKHOLM, Sweden, 11 November 2021 – Today, Quantify Research (QUANTIFY) announced the creation of a new business unit dedicated to Evidence Review and Synthesis as part of its expansion into India and the Asia-Pacific (APAC) market to expand the breadth and depth of their business and service offerings. QUANTIFY is a global partner to the life science industry in the development of real-world evidence generation, data science, health […]
Stina Kettunen joins Quantify!
On Monday we welcomed Stina Kettunen who will strengthen our team as a Project Leader within Market Access. Before joining Quantify, Stina worked as a Health Economics Expert in her home country, Finland. Being the adventurous type, she chose to pack her bags and move to Sweden last Friday to join our Stockholm team. Stinas versatile experience with the market access activities in the Finnish setting, will support Quantify in gaining […]
29th October: World Psoriasis Day
The 29th of October is World Psoriasis Day dedicated to patients with psoriasis and psoriatic arthritis, and this year’s theme is United. Quantify has been highly active in psoriasis research and other activities to support patients.
One example of this research was highlighted earlier this year when Quantify’s CEO Kirk Geale was interviewed by the Swedish Psoriasis Association (Psoriasisförbundet) about his research published in […]
Involve stakeholders and think “Nordic”
In this text, Mary Rosenzweig, Country director Denmark at Quantify Research, gives her perspectives on the changing landscapes in market access and real-world evidence in Denmark and the keys to successful value demonstration of new innovative medicines.
Involve stakeholders and think “Nordic”
Personally, I believe that if we want to support the innovation of new treatments to patients with high need, involvement from all different stakeholders will be necessary: Patients, clinicians, […]